Alterola Biotech, Inc.
ABTI · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $5 | $18 |
| G&A Expenses | $123 | $581 | -$132 | $541 |
| SG&A Expenses | $123 | $581 | -$132 | $541 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$18 |
| Operating Expenses | $123 | $581 | -$127 | $541 |
| Operating Income | -$123 | -$581 | -$73 | -$541 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | -$138 | $200 | -$1,070 |
| Pre-Tax Income | -$123 | -$719 | $127 | -$541 |
| Tax Expense | -$0 | $0 | -$53 | -$6 |
| Net Income | -$123 | -$719 | $180 | -$535 |
| % Margin | – | – | – | – |
| EPS | -0 | -0.001 | 0 | -0.001 |
| % Growth | 77.8% | -550% | 128.6% | – |
| EPS Diluted | -0 | -0.001 | 0 | -0.001 |
| Weighted Avg Shares Out | 800,109 | 807,048 | 805,030 | 807,048 |
| Weighted Avg Shares Out Dil | 800,109 | 807,048 | 806,333 | 807,048 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $6 |
| Depreciation & Amortization | -$0 | $4 | $200 | -$40 |
| EBITDA | -$123 | -$576 | $127 | -$541 |
| % Margin | – | – | – | – |